Predict your next investment

Pipeline Therapeutics company logo
HEALTHCARE | Biotechnology
pipelinetherapeutics.com

See what CB Insights has to offer

Founded Year

2017

Stage

Series C | Alive

Total Raised

$110M

Last Raised

$80M | 1 yr ago

About Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecules for neuroregeneration.

Pipeline Therapeutics Headquarter Location

10578 Science Center Drive Ste. 200

San Diego, California, 92121,

United States

858-333-5280

Latest Pipeline Therapeutics News

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer Report - Q3 2021 Edition - ResearchAndMarkets.com

Nov 23, 2021

November 23, 2021 08:37 AM Eastern Standard Time When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Commercial Analyzer is an interactive Excel-based tool that scores leading pipeline-stage vaccines and therapeutics on a range of clinical and commercial parameters based on available clinical data. The catalyst for the initial release of this analysis, dated September 15, 2021, includes all clinical data readouts and other market-altering events that have occurred since the outbreak's inception. Key Highlights Competitive Assessment: Visual representation of the results of the analyzer, depicting how the leading candidates compete. Product Dashboard: Compilation of all key product features, plus a proprietary SWOT analysis of each product. Clinical Data Summary: Listing of published clinical data for all products included in the analysis. Scope Catalyst: Description of the most recent events impacting the COVID-19 R&D competitive landscape that are accounted for in the analysis Scope of Coverage and Methodology: Discussion of product inclusion criteria and outline of rationale and assumptions Clinical and Commercial Analyzer: Each asset is scored on a set of characteristics that will determine their post-launch success, including clinical features such as efficacy, safety, and dosing regimen and commercial attributes such as price, company reputation, and marketing and sales force strength Competitive Assessment: Visual representation of the results of the analyzer, depicting how the leading candidates compete Product Dashboard: Compilation of all key product features, plus a proprietary SWOT analysis of each product Clinical Data Summary: Listing of published clinical data for all products included in the analysis Key Topics Covered: 1.3 Monitor the COVID-19 Outbreak with The Publisher Epidemiology Indicators 2 Epidemiology 2.2 Epidemiology: Disease Trajectory as of March 25, 2020 2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020 2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020 2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020 2.6 Epidemiology Forecast: United States 3 Pipeline Overview 3.2 Pipeline Therapeutics: Breakdown by Molecule Type 3.3 Pipeline Therapeutics: Breakdown by Type of Developer 3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III) 3.5 Pipeline Therapeutics: Preclinical-Stage Candidates 3.6 Pipeline Therapeutics: Currently Available Data 3.7 Pipeline Vaccines: Breakdown by Phase 3.8 Pipeline Vaccines: Breakdown by Developer Type 3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates 4 Pipeline Overview 4.2 Pipeline Therapeutics: Breakdown by Molecule Type 4.3 Pipeline Therapeutics: Breakdown by Type of Developer 4.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III) 4.5 Pipeline Therapeutics: Preclinical-Stage Candidates 4.6 Pipeline Therapeutics: Currently Available Data 4.7 Pipeline Vaccines: Breakdown by Phase 4.8 Pipeline Vaccines: Breakdown by Developer Type 4.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates 5 Clinical Trials 5.2 Clinical Trials for Therapeutics and Vaccines 5.3 Clinical Trials: Overview by Region 5.4 Clinical Trials for Therapeutics: Leading Sponsors 5.5 Clinical Trials: Leading Industry Sponsors 5.6 Trends in Trial Design 6 Deal-making Trends

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pipeline Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pipeline Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,532 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Pipeline Therapeutics Patents

Pipeline Therapeutics has filed 5 patents.

The 3 most popular patent topics include:

  • Audiology
  • Auditory system
  • Ear
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/12/2017

2/23/2021

Auditory system, Ear, Audiology, Hearing, Ear procedures

Grant

Application Date

12/12/2017

Grant Date

2/23/2021

Title

Related Topics

Auditory system, Ear, Audiology, Hearing, Ear procedures

Status

Grant

Pipeline Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Pipeline Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.